223 related articles for article (PubMed ID: 18671871)
1. Molecular epidemiology of drug-resistant malaria in western Kenya highlands.
Zhong D; Afrane Y; Githeko A; Cui L; Menge DM; Yan G
BMC Infect Dis; 2008 Jul; 8():105. PubMed ID: 18671871
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.
Ghanchi NK; Ursing J; Beg MA; Veiga MI; Jafri S; Mårtensson A
Malar J; 2011 Jan; 10():18. PubMed ID: 21272384
[TBL] [Abstract][Full Text] [Related]
3. Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).
Berzosa P; Esteban-Cantos A; García L; González V; Navarro M; Fernández T; Romay-Barja M; Herrador Z; Rubio JM; Ncogo P; Santana-Morales M; Valladares B; Riloha M; Benito A
Malar J; 2017 Jan; 16(1):28. PubMed ID: 28086777
[TBL] [Abstract][Full Text] [Related]
4. Genetic structure of Plasmodium falciparum populations between lowland and highland sites and antimalarial drug resistance in Western Kenya.
Bonizzoni M; Afrane Y; Baliraine FN; Amenya DA; Githeko AK; Yan G
Infect Genet Evol; 2009 Sep; 9(5):806-12. PubMed ID: 19398039
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran.
Zakeri S; Afsharpad M; Raeisi A; Djadid ND
Malar J; 2007 Nov; 6():148. PubMed ID: 17999755
[TBL] [Abstract][Full Text] [Related]
6. Molecular Evidence for
Wedam J; Tacoli C; Gai PP; Siegert K; Kulkarni SS; Rasalkar R; Boloor A; Jain A; Mahabala C; Baliga S; Shenoy D; Devi R; Gai P; Mockenhaupt FP
Am J Trop Med Hyg; 2018 Dec; 99(6):1508-1510. PubMed ID: 30398146
[TBL] [Abstract][Full Text] [Related]
7. Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.
Mbogo GW; Nankoberanyi S; Tukwasibwe S; Baliraine FN; Nsobya SL; Conrad MD; Arinaitwe E; Kamya M; Tappero J; Staedke SG; Dorsey G; Greenhouse B; Rosenthal PJ
Am J Trop Med Hyg; 2014 Jul; 91(1):54-61. PubMed ID: 24799371
[TBL] [Abstract][Full Text] [Related]
8. Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.
Grais RF; Laminou IM; Woi-Messe L; Makarimi R; Bouriema SH; Langendorf C; Amambua-Ngwa A; D'Alessandro U; Guérin PJ; Fandeur T; Sibley CH
Malar J; 2018 Feb; 17(1):98. PubMed ID: 29486766
[TBL] [Abstract][Full Text] [Related]
9. Comparative assessment on the prevalence of mutations in the Plasmodium falciparum drug-resistant genes in two different ecotypes of Odisha state, India.
Kar NP; Chauhan K; Nanda N; Kumar A; Carlton JM; Das A
Infect Genet Evol; 2016 Jul; 41():47-55. PubMed ID: 26988711
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of pfdhfr and pfdhps mutations in Plasmodium falciparum associated with drug resistance among pregnant women receiving IPTp-SP at Msambweni County Referral Hospital, Kwale County, Kenya.
Gikunju SW; Agola EL; Ondondo RO; Kinyua J; Kimani F; LaBeaud AD; Malhotra I; King C; Thiong'o K; Mutuku F
Malar J; 2020 May; 19(1):190. PubMed ID: 32448228
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.
Wurtz N; Fall B; Pascual A; Diawara S; Sow K; Baret E; Diatta B; Fall KB; Mbaye PS; Fall F; Diémé Y; Rogier C; Bercion R; Briolant S; Wade B; Pradines B
Malar J; 2012 Jun; 11():197. PubMed ID: 22694921
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria prevention during pregnancy in eastern-coast of Tanzania.
Bwire GM; Mikomangwa WP; Kilonzi M
BMC Infect Dis; 2020 Jul; 20(1):530. PubMed ID: 32698764
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola.
Figueiredo P; Benchimol C; Lopes D; Bernardino L; do Rosário VE; Varandas L; Nogueira F
Malar J; 2008 Nov; 7():236. PubMed ID: 19014684
[TBL] [Abstract][Full Text] [Related]
14. Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi.
Artimovich E; Schneider K; Taylor TE; Kublin JG; Dzinjalamala FK; Escalante AA; Plowe CV; Laufer MK; Takala-Harrison S
J Infect Dis; 2015 Sep; 212(5):694-701. PubMed ID: 25672905
[TBL] [Abstract][Full Text] [Related]
15. Characterization of putative drug resistant biomarkers in Plasmodium falciparum isolated from Ghanaian blood donors.
Aninagyei E; Duedu KO; Rufai T; Tetteh CD; Chandi MG; Ampomah P; Acheampong DO
BMC Infect Dis; 2020 Jul; 20(1):533. PubMed ID: 32698879
[TBL] [Abstract][Full Text] [Related]
16. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
Bamaga OA; Mahdy MA; Lim YA
Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
[TBL] [Abstract][Full Text] [Related]
17. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
Kaingona-Daniel EP; Gomes LR; Gama BE; Almeida-de-Oliveira NK; Fortes F; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
Malar J; 2016 Jun; 15():309. PubMed ID: 27267365
[TBL] [Abstract][Full Text] [Related]
18. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
Madkhali AM; Al-Mekhlafi HM; Atroosh WM; Ghzwani AH; Zain KA; Abdulhaq AA; Ghailan KY; Anwar AA; Eisa ZM
Malar J; 2020 Dec; 19(1):446. PubMed ID: 33267841
[TBL] [Abstract][Full Text] [Related]
19. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R
Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
Yaqoob A; Khattak AA; Nadeem MF; Fatima H; Mbambo G; Ouattara A; Adams M; Zeeshan N; Takala-Harrison S
Malar J; 2018 Dec; 17(1):471. PubMed ID: 30558587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]